98%
921
2 minutes
20
Engineered Cementitious Composites (ECC) are highly regarded in construction owing to their tensile ductility and crack control capabilities, making them suitable for various structural applications. The accumulation of multi-walled carbon nanotubes (MWCNTs) further enhances their mechanical properties. However, there's a significant knowledge gap concerning MWCNTs-ECC impact resistance. The objective of this study is to tackle the challenges associated with evaluating, optimizing, and predicting MWCNTs-ECC impact resistance to ensure its safe and widespread use in critical infrastructure by applying response surface methodology (RSM). Moreover, the 13 mixtures of ECC combined with several quantities of PVA fiber and MWCNTs as input elements were utilized to calculate the first (E1) and final (E2) impact energies. The findings demonstrated that the MWCNTs-ECC combinations' impact resistance improved as the input ingredient concentrations increased. Besides, the optimum E1 and E2 of ECC combined with 1% of PVA fiber were noted by 1398 Joules and 12,956 Joules at 0.065% of MWCNTs on 28 days respectively. Furthermore, Response prediction models for E1 and E2 were created, and after being validated with an analysis of variance (ANOVA), it was determined that they had high R readings of 99.30% and 99.07%, correspondingly. The optimization process produced an ideal number of input variables for MWCNTs and PVA fiber, respectively, of 0.066% and 1%, with a desirability value of 100%. Moreover, it is recommended that the usage of 0.066% of MWCNTs in ECC combined with 1.0-1.50% PVA fiber provides optimum results for the construction industry.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480454 | PMC |
http://dx.doi.org/10.1038/s41598-024-75641-5 | DOI Listing |
Eur J Case Rep Intern Med
August 2025
Dermatology Department, Ain Shams University Hospital, Cairo, Egypt.
Background: Dissecting cellulitis of the scalp (DCS) is a rare, chronic neutrophilic dermatosis that is often refractory to conventional therapies.
Case Report: We present a 29-year-old male with treatment-resistant DCS who achieved rapid and sustained remission following off-label use of tofacitinib, a Janus kinase (JAK) inhibitor. Previous therapies, including antibiotics, corticosteroids, and isotretinoin, had failed.
Front Immunol
September 2025
Department of Pathological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, United States.
Oncolytic virotherapy (OVT) has emerged as a promising and innovative cancer treatment strategy that harnesses engineered viruses to selectively infect, replicate within, and destroys malignant cells while sparing healthy tissues. Beyond direct oncolysis, oncolytic viruses (OVs) exploit tumor-specific metabolic, antiviral, and immunological vulnerabilities to reshape the tumor microenvironment (TME) and initiate systemic antitumor immunity. Despite promising results from preclinical and clinical studies, several barriers, including inefficient intratumoral virus delivery, immune clearance, and tumor heterogeneity, continue to limit the therapeutic advantages of OVT as a standalone modality and hindered its clinical success.
View Article and Find Full Text PDFiScience
September 2025
Department of Molecular Pathology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, QingDao, Shandong 266300, China.
Gliomas are common primary brain tumors in the central nervous system, characterized by invasiveness, heterogeneity, and drug resistance, posing a threat to patients' lives. Glioblastoma (IDH wild-type) exhibits the highest invasiveness and mortality rate, making it a challenging therapeutic target. This review first outlines the characteristics of gliomas and their impact on the nervous system, then explores the pathological mechanisms and unique behaviors of glioblastoma (IDH wild-type), as well as the influence of the nervous system on its occurrence and progression.
View Article and Find Full Text PDFFront Nutr
August 2025
Faculty of Medicine, Department of Psychiatry, Medical University of Gdańsk, Gdańsk, Poland.
Unlabelled: Mood disorders, including major depressive disorder (MDD) and bipolar disorder (BP), significantly impact global health, with MDD affecting over 300 million people and BP affecting approximately 2% of the world's population. Ketamine, originally an anesthetic, has emerged as a promising treatment for patients with treatment-resistant depression (TRD), due to its unique pharmacological properties, such as N-methyl-D-aspartate (NMDA) receptor antagonism and anti-inflammatory effects. The potential of ketamine in treating depression has sparked debate regarding its effects on appetite.
View Article and Find Full Text PDFFront Allergy
August 2025
Department of Surgery, University of Auckland, Auckland, New Zealand.
Allergic rhinitis (AR) and chronic rhinosinusitis (CRS) are common respiratory conditions that significantly impact patient health and contribute to substantial healthcare burdens. While conventional treatments offer symptom relief, many patients continue to experience persistent symptoms, side effects, or resistance to standard therapies. This highlights the growing need for novel, non-invasive, and sustainable therapeutic strategies to manage chronic airway inflammation.
View Article and Find Full Text PDF